A total of @ women with recurrent urinary tract infections and dysfunctional voiding were included and randomly assigned to the following groups : uroflowmetry biofeedback ( group @ ) , @-adrenoceptor antagonists ( group @ ) , uroflowmetry biofeedback combined with @-adrenoceptor antagonists ( group @ ) and no treatment ( group @ ) .